US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 17, 2018 (8 years ago)

Thymosin Beta-4

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance.

What was recalled

Thymosin Beta-4, 15 mg Injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684

Recalling firm
Promise Pharmacy, LLC
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0447-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Beta recalls

See all
Class II · Moderate risk Ongoing

Thymosin Beta-4

Reason Lack of Assurance of Sterility

GenoGenix LLC D-0087-2026
Class II · Moderate risk Ongoing

Labetalol Hydrochloride Injection

Reason Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Pfizer Inc. D-0565-2024
Class II · Moderate risk Terminated

labetalol HCl 20 mg/4mL Injection

Reason Lack of Assurance of Sterility

SCA Pharmaceuticals, LLC NDC 70004-0700-28 D-0411-2024
Class I · High risk Terminated

Betaxolol Tablets

Reason Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.

KVK-Tech, Inc. NDC 10702-013-01 D-0049-2024